| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $3.7M | -38.4% |
| R&D Expense | $39.1M | +138.0% |
| SG&A Expense | $114.1M | +63.4% |
| Operating Income | -$172.8M | -70.5% |
| Pre-tax Income | -$54.0M | -219.6% |
| Income Tax | $526K | — |
| Net Income | -$32.2M | -132.5% |
| EPS (Basic) | -$0.13 | -85.7% |
| EPS (Diluted) | -$0.13 | -85.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $60.6M | -86.4% |
| Accounts Receivable | $29K | -98.9% |
| Inventory | $35.6M | +84.7% |
| Current Assets | $312.9M | -36.8% |
| Total Assets | $374.9M | -29.3% |
| Current Liabilities | $45.9M | +47.0% |
| Total Liabilities | $67.8M | -57.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$149.1M | -56.6% |
| Capital Expenditures | $14.1M | -2.7% |
| Investing Cash Flow | -$216.2M | -812.0% |
| Financing Cash Flow | -$14.3M | -102.6% |
| Free Cash Flow | -$163.2M | -48.8% |
| Stockholders' Equity |
| $307.8M |
| -18.0% |